FR2305990B1 - - Google Patents

Info

Publication number
FR2305990B1
FR2305990B1 FR7510252A FR7510252A FR2305990B1 FR 2305990 B1 FR2305990 B1 FR 2305990B1 FR 7510252 A FR7510252 A FR 7510252A FR 7510252 A FR7510252 A FR 7510252A FR 2305990 B1 FR2305990 B1 FR 2305990B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7510252A
Other languages
French (fr)
Other versions
FR2305990A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre SA
Original Assignee
Pierre Fabre SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre SA filed Critical Pierre Fabre SA
Priority to FR7510252A priority Critical patent/FR2305990A1/fr
Priority to BE165450A priority patent/BE839893A/xx
Priority to JP51034585A priority patent/JPS51121511A/ja
Priority to GB13292/76A priority patent/GB1543962A/en
Priority to DE2613943A priority patent/DE2613943C3/de
Priority to ES446637A priority patent/ES446637A1/es
Publication of FR2305990A1 publication Critical patent/FR2305990A1/fr
Application granted granted Critical
Publication of FR2305990B1 publication Critical patent/FR2305990B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0266—Klebsiella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0283—Shigella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR7510252A 1975-04-02 1975-04-02 Preparation de vaccins a base d'acides nucleiques arn associes a des polysaccharides extraits de germes microbiens Granted FR2305990A1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR7510252A FR2305990A1 (fr) 1975-04-02 1975-04-02 Preparation de vaccins a base d'acides nucleiques arn associes a des polysaccharides extraits de germes microbiens
BE165450A BE839893A (fr) 1975-04-02 1976-03-22 Preparation de vaccins a base d'acides nucleiques arn associes a des polysaccharides extraits de germes microbiens.
JP51034585A JPS51121511A (en) 1975-04-02 1976-03-31 Production of vaccine based on polysaccharid adduct nucleotic acid extracted from microorganism bacterium
GB13292/76A GB1543962A (en) 1975-04-02 1976-04-01 Acellular vaccines
DE2613943A DE2613943C3 (de) 1975-04-02 1976-04-01 Herstellung von Vaeeinen auf Ribonucleinsäurebasis
ES446637A ES446637A1 (es) 1975-04-02 1976-04-02 Procedimiento para la preparacion de vacunas acelulares.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7510252A FR2305990A1 (fr) 1975-04-02 1975-04-02 Preparation de vaccins a base d'acides nucleiques arn associes a des polysaccharides extraits de germes microbiens

Publications (2)

Publication Number Publication Date
FR2305990A1 FR2305990A1 (fr) 1976-10-29
FR2305990B1 true FR2305990B1 (es) 1980-01-25

Family

ID=9153417

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7510252A Granted FR2305990A1 (fr) 1975-04-02 1975-04-02 Preparation de vaccins a base d'acides nucleiques arn associes a des polysaccharides extraits de germes microbiens

Country Status (6)

Country Link
JP (1) JPS51121511A (es)
BE (1) BE839893A (es)
DE (1) DE2613943C3 (es)
ES (1) ES446637A1 (es)
FR (1) FR2305990A1 (es)
GB (1) GB1543962A (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4389396A (en) 1979-12-21 1983-06-21 Pierre Fabre, S.A. Immunostimulating preparations based on ribosomal RNA's and a process for the preparation of the RNA's

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2253499B1 (es) * 1973-12-10 1977-11-04 Fabre Sa Pierre
FR2444464A1 (fr) 1978-12-19 1980-07-18 Fabre Sa Pierre Proteoglycanes bacteriens purifies, procede pour leur preparation et vaccin les contenant
FR2475900A1 (fr) * 1980-02-20 1981-08-21 Fabre Sa Pierre Complexe vaccinal contenant un antigene specifique et vaccin le contenant
FR2596064B1 (fr) * 1986-03-18 1990-02-02 Pf Medicament Procedes industriels de fabrication de vaccins ribosomaux et vaccins ribosomaux obtenus
AR055311A1 (es) 2006-02-17 2007-08-15 H P B S A Composicion farmaceutica solida para el tratamiento de la hiperplasia benigna de prostata, procedimiento para su elaboracion y metodo de tratamiento

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4389396A (en) 1979-12-21 1983-06-21 Pierre Fabre, S.A. Immunostimulating preparations based on ribosomal RNA's and a process for the preparation of the RNA's

Also Published As

Publication number Publication date
DE2613943C3 (de) 1980-03-06
DE2613943A1 (de) 1976-10-14
JPS51121511A (en) 1976-10-23
ES446637A1 (es) 1977-06-01
DE2613943B2 (es) 1979-07-05
BE839893A (fr) 1976-09-22
GB1543962A (en) 1979-04-11
FR2305990A1 (fr) 1976-10-29

Similar Documents

Publication Publication Date Title
FR2331598B1 (es)
FR2305990B1 (es)
JPS5610057B2 (es)
JPS5726776Y2 (es)
JPS51113494U (es)
JPS5434967Y2 (es)
JPS5555004Y2 (es)
FR2297816B1 (es)
JPS5220110U (es)
JPS5255873U (es)
JPS5232633U (es)
JPS5211394U (es)
JPS5210545U (es)
JPS51162454U (es)
JPS5234450U (es)
JPS51104043U (es)
JPS5247774U (es)
FI752970A (es)
CH604335A5 (es)
CH601979A5 (es)
CH606842A5 (es)
CH606830A5 (es)
CH604943A5 (es)
CH604781A5 (es)
CH599590B5 (es)

Legal Events

Date Code Title Description
TP Transmission of property